117 related articles for article (PubMed ID: 38291579)
1. Association of Serum Osteoprotegerin With Vascular Calcification, and Cardiovascular and Graft Outcomes in Kidney Transplant Patients: Results From the KNOW-KT.
Jeon HJ; Ryu JH; Kim MG; Huh KH; Lee KW; Kim CD; Kang KP; Ro H; Han S; Yang J;
Transplantation; 2024 May; 108(5):1239-1248. PubMed ID: 38291579
[TBL] [Abstract][Full Text] [Related]
2. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
4. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
[TBL] [Abstract][Full Text] [Related]
5. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC
Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
[TBL] [Abstract][Full Text] [Related]
7. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
Nakashima A; Carrero JJ; Qureshi AR; Hirai T; Takasugi N; Ueno T; Taniguchi Y; Lindholm B; Yorioka N
Osteoporos Int; 2011 Jun; 22(6):1695-701. PubMed ID: 20812007
[TBL] [Abstract][Full Text] [Related]
8. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients.
Hsu BG; Shih MH; Chen YC; Ho GJ; Lin TY; Lee MC
Tohoku J Exp Med; 2015 Aug; 236(4):247-53. PubMed ID: 26156285
[TBL] [Abstract][Full Text] [Related]
9. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM;
Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
[TBL] [Abstract][Full Text] [Related]
10. Association between sclerostin levels and vascular outcomes in kidney transplantation patients.
Koh HB; Ryu JH; Kim SS; Kim MG; Park JB; Kim CD; Kang KP; Ro H; Han SY; Huh KH; Yang J;
J Nephrol; 2023 Sep; 36(7):2091-2109. PubMed ID: 37751127
[TBL] [Abstract][Full Text] [Related]
11. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients.
Hjelmesaeth J; Ueland T; Flyvbjerg A; Bollerslev J; Leivestad T; Jenssen T; Hansen TK; Thiel S; Sagedal S; Røislien J; Hartmann A
J Am Soc Nephrol; 2006 Jun; 17(6):1746-54. PubMed ID: 16687626
[TBL] [Abstract][Full Text] [Related]
12. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of pretransplant aortic arch calcification evaluation for kidney transplant outcome prediction in one year follow-up.
Laucyte-Cibulskiene A; Boreikaite E; Aucina G; Gudynaite M; Rudminiene I; Anisko S; Vareikiene L; Gumbys L; Valanciene D; Ryliskyte L; Strupas K; Rimsevicius L; Miglinas M
Ren Fail; 2018 Nov; 40(1):201-208. PubMed ID: 29619867
[TBL] [Abstract][Full Text] [Related]
14. Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.
Scialla JJ; Leonard MB; Townsend RR; Appel L; Wolf M; Budoff MJ; Chen J; Lustigova E; Gadegbeku CA; Glenn M; Hanish A; Raj D; Rosas SE; Seliger SL; Weir MR; Parekh RS;
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2612-9. PubMed ID: 21940840
[TBL] [Abstract][Full Text] [Related]
15. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
[TBL] [Abstract][Full Text] [Related]
16. Radiographic assessment of vascular calcification, aortic pulse wave velocity, ankle-brachial index and fibroblast growth factor-23 in chronic hemodialysis patients.
Breznik S; Ekart R; Hren M; Rupreht M; Balon BP
Ther Apher Dial; 2013 Aug; 17(4):378-83. PubMed ID: 23931875
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.
Ozkok A; Caliskan Y; Sakaci T; Erten G; Karahan G; Ozel A; Unsal A; Yildiz A
Clin J Am Soc Nephrol; 2012 Jun; 7(6):965-73. PubMed ID: 22490874
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.
Ramirez-Sandoval JC; Casanova I; Villar A; Gomez FE; Cruz C; Correa-Rotter R
Perit Dial Int; 2016; 36(3):262-8. PubMed ID: 26293840
[TBL] [Abstract][Full Text] [Related]
19. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of vascular calcification and mortality in patients with ESRD.
Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS
Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
